Web News Insider
-
Opioid Crisis Moved From Painkillers to Heroin to Fentanyl in Waves, Study Finds
WASHINGTON, July 16 — The opioid epidemic, described by doctors and researchers as “one of the most devastating public health catastrophes of…
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Emotional Dysregulation in Children and Teens: Causes, Warning Signs and Related Conditions
MANILA — For families across Asia, a child’s explosive tantrum or a teenager’s sudden withdrawal can feel bewildering. But for many, these…
-
Drug-Resistant Bacteria: How Antibiotic Success Fed the Superbug Problem
ISLAMABAD, July 8 — The story of antibiotics is one of modern medicine’s greatest triumphs, a narrative of lives snatched back from…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
How insulin went from dog experiments in 1921 to modern diabetes treatment
WASHINGTON, July 16 — The Association for Diagnostics & Laboratory Medicine, the global scientific and medical professional organization formerly known as the…
-
Alzheimer’s Amyloid Beta Explained: How Plaques Form and Two New Blood Tests Detect Them
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
Indiana Study Links Bowel Cancer Treatment Delays of 47 Days or More to Higher Spread Risk
BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…
-
Colorectal cancer is rising in adults under 50 as many patients are told they are too young
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
-
Large U.S. Study Links Cannabis Use Disorder to Nearly Four Times the Lung Cancer Risk
WASHINGTON, July 15 — A new case-control study, the largest of its kind ever conducted in the United States, has delivered a…
-
Ernexa Plans Fourth-Quarter First-in-Human Trial of ERNA-101 in Ovarian Cancer
SAN FRANCISCO, July 15 — Ernexa Therapeutics, a biotechnology company operating in the U.S. healthcare sector, is preparing to advance its lead…
-
Ernexa Moves ERNA-101 Into GMP Manufacturing Ahead of Planned IND Filing
KARACHI, July 15 — Ernexa Therapeutics is moving toward a planned first-in-human Phase 1 study for its lead cancer candidate, ERNA-101, though…
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
Ernexa Plans IND Filing in Q3 and Ovarian Cancer Trial in Q4 2026
NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…
-
Heavy Marijuana Use Linked to Nearly Four Times the Lung Cancer Risk in Large U.S. Study
WASHINGTON, July 15 — A senior epidemiologist at a major U.S. university or government agency is the lead researcher behind a new…
-
Bowel Cancer Five-Year Survival Falls From 91.5% at Early Stage to 16.2% at Stage 4
INDIANAPOLIS, July 15 — A study released yesterday by the Indiana University School of Medicine documents a stark divide in bowel cancer…
-
Ernexa Therapeutics Advances ERNA-101 to First-in-Human Trial Planning
SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…
-
New Alzheimer’s Drug Kisunla Carries Significant Brain Risk Factors
The U.S. Food and Drug Administration approved Eli Lilly’s monoclonal antibody donanemab, marketed as Kisunla, on July 15, 2024. The drug is…
-
Akeso gets FDA and China clearance for Phase II cadonilimab liver cancer trial
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
Akeso starts US Phase II cadonilimab trial in gastric cancer with Memorial Sloan Kettering
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Pioneering pharmacologist honored for breast cancer breakthrough
WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…
-
How Vaccines Train the Immune System and Cut Deaths from Disease
ASTANA, July 14 — The global vaccine market, a sector that directly shapes public health outcomes from Central Asia to the Americas,…
-
Edward Jenner Performed First Vaccination In 1796 Using Cowpox
LONDON, July 14 — The first vaccination in history was performed in 1796 by English physician Edward Jenner, who inoculated a boy…
-
How the US Dollar Became the World’s Dominant Currency
LONDON, July 14 — There is a quiet, almost invisible machine at the heart of global finance, and for nearly eighty years…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992